New drug combo tested to stop chemo sickness in Women's cancers
NCT ID NCT06007586
Summary
This study aimed to find the best way to prevent severe nausea and vomiting caused by a common chemotherapy regimen for gynecologic cancers like ovarian and cervical cancer. Researchers tested whether adding a drug called aprepitant to the standard two-drug anti-nausea treatment was more effective. The trial involved 143 patients who received the new combination and then switched to the standard treatment, or vice versa, to compare the results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dengfeng Wang
Chengdu, Sichua, 610041, China
-
Sichuan Cancer Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.